Insider Transactions in Q2 2025 at United Therapeutics Corp (UTHR)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 21
2025
|
Raymond Dwek |
SELL
Open market or private sale
|
Direct |
3,000
-63.16%
|
$855,000
$285.57 P/Share
|
|
Apr 21
2025
|
Raymond Dwek |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+38.71%
|
$525,000
$175.43 P/Share
|
|
Apr 17
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
11,000
-6.24%
|
$3,102,000
$282.95 P/Share
|
|
Apr 17
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+18.71%
|
$1,287,000
$117.76 P/Share
|
|
Apr 14
2025
|
Raymond Dwek |
SELL
Open market or private sale
|
Direct |
3,000
-63.16%
|
$855,000
$285.16 P/Share
|
|
Apr 14
2025
|
Raymond Dwek |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+38.71%
|
$525,000
$175.43 P/Share
|
|
Apr 07
2025
|
Raymond Dwek |
SELL
Open market or private sale
|
Direct |
4,000
-69.57%
|
$1,136,000
$284.55 P/Share
|
|
Apr 07
2025
|
Raymond Dwek |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+41.03%
|
$700,000
$175.43 P/Share
|
|
Apr 03
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
11,000
-4.22%
|
$3,344,000
$304.13 P/Share
|
|
Apr 03
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+18.71%
|
$1,287,000
$117.76 P/Share
|